Cargando…
A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019
Autores principales: | Zhang, Fengqin, Wei, Yanqiu, He, Li, Zhang, Huilan, Hu, Qiongjie, Yue, Huihui, He, Jianhan, Dai, Huaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812696/ https://www.ncbi.nlm.nih.gov/pubmed/34855641 http://dx.doi.org/10.1097/CM9.0000000000001614 |
Ejemplares similares
-
Outpatient strategies and the changing SARS-CoV-2 epidemic
por: Wei, Yanqiu, et al.
Publicado: (2020) -
Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature
por: He, Jianhan, et al.
Publicado: (2021) -
Impact of coronavirus disease 2019 on the clinical diagnosis and treatment of breast cancer in China
por: Si, Yi-Ran, et al.
Publicado: (2021) -
Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019
por: Huang, Lan, et al.
Publicado: (2020) -
Clinical characteristics of 1327 patients with coronavirus disease 2019 (COVID-19) in the largest Fangcang shelter hospital in Wuhan
por: Lu, Chong, et al.
Publicado: (2021)